We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Bevacizumab vs Dacarbazine in Metastatic Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01705392
Recruitment Status : Terminated (Lack of financing of the study drug. Not sufficient financial support.)
First Posted : October 12, 2012
Last Update Posted : February 24, 2017
Sponsor:
Collaborators:
The Norwegian Melanoma Group
Norwegian Cancer Society
Information provided by (Responsible Party):
Haukeland University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : February 20, 2017
  Study Completion Date : February 20, 2017